We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Respiratory Syncytial Virus (RSV)
Protects against Respiratory Syncytial Virus (RSV), a common cause of serious breathing issues
From 1 September 2024, those who turn 75 and those age 75 to 79 will be eligible for a free vaccine to protect them from respiratory syncytial virus (RSV).
RSV is an infectious disease of the airways and lungs. RSV infection often causes symptoms similar to a cold, including:
- cough
- sore throat
- sneezing
- a runny or blocked nose
Published: Aug 19, 2024